查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493293

幹細胞治療市場規模、佔有率、趨勢分析報告：依治療類型、治療應用、地區、細分市場預測，2024-2030

Stem Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type, By Therapeutic Application (Oncology, Cardiovascular Disease, Musculoskeletal Disorders), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

幹細胞治療市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球幹細胞治療市場規模將達到16.701億美元，預計2024年至2030年複合年成長率為24.15%。

幹細胞研究和技術的進步徹底改變了再生醫學領域。幹細胞分離、表徵和操作技術的突破性進展使研究人員能夠更準確、更有效地利用幹細胞的治療潛力。例如，2023年5月，EPROCELL推出了合約開發和受託製造廠商（CDMO）服務，以製造源自間質幹細胞（MSC）的先進治療藥品（ATMP）。與 Histocell 的合作促進了這一擴張。這些進步正在推動從慢性疾病到退化性疾病等多種疾病的創新治療方法的開發。

慢性病和退化性疾病的日益普及刺激了對新治療方法的需求。心血管疾病、神經退化性疾病、整形外科損傷和自體免疫疾病等疾病對醫療保健提出了重大挑戰，並推動了對創新治療方法的探索。例如，《柳葉刀神經病學》雜誌上發表的一項研究預測，到 2040 年，受帕金森氏症影響的人數將大幅增加。這些預測數字令人震驚，因為它們表明全球受這種神經退化性疾病影響的人數可能會加倍，達到至少 1,290 萬人。幹細胞療法在解決這些複雜疾病方面具有廣闊的前景，包括促進組織再生、調節免疫反應和恢復器官功能，為疾病管理和治療提供新途徑。

隨著投資者認知到突破性的醫療進步和豐厚回報的潛力，全球市場的投資正在穩步增加。資本的湧入推動了研究、開發和商業化工作，推動了整體市場的成長。隨著對再生醫學和個人化醫療保健的日益重視，市場有望繼續擴大，並為與各種醫療狀況作鬥爭的患者提供創新的治療方法和新的希望。

幹細胞治療市場報告亮點

  • 按治療類型分類，到2023年，異體幹細胞治療領域將以68.41%的收益佔有率引領市場，預計在預測期內將以26.74%的複合年成長率成長最快。
  • 從治療應用來看，在持續研究和臨床進展的推動下，包括血液疾病和神經系統疾病在內的其他治療領域將在 2023 年以 72.75% 的最大銷售佔有率引領市場。
  • 北美以 2023 年最高收益佔有率50.11% 佔據市場主導地位，由於幾個關鍵因素，預計在預測期內將以 28.07% 的最快複合年成長率成長。市場成長是由有利的法律規範、慢性病發病率上升和技術進步所推動的。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章幹細胞治療市場：依治療類型的業務分析

  • 細分儀表板
  • 全球幹細胞治療市場治療類型波動分析
  • 2018-2030年全球幹細胞治療市場規模與趨勢分析（依治療類型）
  • 同種異體幹細胞療法
  • 自體幹細胞治療

第5章幹細胞治療市場：治療應用的商業分析

  • 細分儀表板
  • 全球幹細胞治療市場的治療應用與波動分析
  • 2018-2030年全球幹細胞治療市場規模與趨勢分析（依治療應用）
  • 腫瘤學
  • 心血管疾病（CVD）
  • 肌肉骨骼疾病
  • 其他

第6章幹細胞治療市場：依治療類型和治療應用進行區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測及趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 世界其他地區

第7章 競爭格局

  • 參與企業
  • 策略規劃
  • 2023 年企業市場分析
  • 參與企業概況
    • Bluebird Bio, Inc.
    • NIPRO
    • Orchard Therapeutics plc
    • Pharmicell Co., Ltd.
    • CorestemChemon Inc.
    • ANTEROGEN.CO.,LTD.
    • Holostem Srl
    • Vertex Pharmaceuticals, Inc.
    • Cleveland Cord Blood Center
    • Gamida Cell Ltd.
Product Code: GVR-4-68040-274-4

Stem Cell Therapy Market Growth & Trends:

The global stem cell therapy market size is anticipated to reach USD 1,670.1 million by 2030 and is projected to grow at a CAGR of 24.15% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is propelled by several key factors that underscore both scientific advancements and evolving healthcare needs.Advancements in stem cell research and technology have revolutionized the landscape of regenerative medicine. Breakthroughs in stem cell isolation, characterization, and manipulation techniques have empowered researchers to harness the therapeutic potential of stem cells with greater precision and efficacy. For instance, in May 2023, EPROCELL introduced Contract Development and Manufacturing Organization (CDMO) services for producing Advanced Therapies Medicinal Products (ATMPs) derived from mesenchymal stem cells (MSC). This expansion is facilitated by a partnership with Histocell. These advancements have spurred the development of innovative therapies targeting a wide spectrum of medical conditions, from chronic diseases to degenerative disorders.

The increasing prevalence of chronic and degenerative diseases has fueled the demand for novel treatment modalities. Conditions such as cardiovascular diseases, neurodegenerative disorders, orthopedic injuries, and autoimmune diseases pose significant healthcare challenges, driving the search for innovative therapeutic approaches. For instance, a study published in The Lancet Neurology has anticipated a significant increase in the number of individuals affected by Parkinson's disease by the year 2040. The projected figure is alarming, as it suggests that the number of people living with this neurodegenerative disorder may double, reaching at least 12.9 million worldwide. Stem cell therapies hold immense promise in addressing these complex diseases by promoting tissue regeneration, modulating immune responses, and restoring organ function, thus offering new avenues for disease management and treatment.

Investment in the global market has been steadily increasing as investors recognize the potential for groundbreaking medical advancements and lucrative returns. This influx of capital fuels research, development, and commercialization efforts, driving the overall market growth. With a growing emphasis on regenerative medicine and personalized healthcare, the market is poised for continued expansion, offering innovative treatments and renewed hope to patients grappling with a wide range of medical conditions.

Stem Cell Therapy Market Report Highlights:

  • Based on therapy type, the allogeneic stem cell therapies segment led the market with the largest revenue share of 68.41% by 2023 and is anticipated to grow at the fastest CAGR of 26.74% during the forecast period, propelled by a convergence of factors contributing to its expansion such as increasing landscape of research and clinical trials within the field
  • Based on therapeutic application, the other therapeutic segment including diseases such as blood disorders, and neurological disorders led the market with the largest revenue share of 72.75% in 2023, fueled by ongoing research and clinical advancements
  • North America dominated the market with the largest revenue share of 50.11% in 2023 and is anticipated to grow at the fastest CAGR of 28.07% during the forecast period, driven by several key factors. The market growth is facilitated by favorable regulatory frameworks, rising rates of chronic diseases, and technological improvements

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Therapy Type
    • 1.2.2. Therapeutic Application
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing research & development in stem cell therapy
      • 3.2.1.2. Increasing prevalence of chronic diseases
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of stem cell therapy
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Stem Cell Therapy Market: Therapy Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Stem Cell Therapy Market Therapy Type Movement Analysis
  • 4.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapy Type, 2018 to 2030 (USD Million)
  • 4.4. Allogeneic Stem Cell Therapies
    • 4.4.1. Global Allogeneic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Hematopoietic Stem Cell Therapies
      • 4.4.2.1. Global Hematopoietic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Mesenchymal Stem Cell Therapies
      • 4.4.3.1. Global Mesenchymal Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Autologous Stem Cell Therapies, by Type
    • 4.5.1. Global Autologous Stem Cell Therapies, by Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. BM, Blood, & Umbilical Cord-derived Stem Cells
      • 4.5.2.1. Global BM, Blood, & Umbilical Cord-derived Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Adipose-Derived Cells
      • 4.5.3.1. Global Adipose-Derived Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Stem Cell Therapy Market: Therapeutic Application Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Stem Cell Therapy Market Therapeutic Application, Movement Analysis
  • 5.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapeutic Application, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular Disease (CVD)
    • 5.5.1. Global Cardiovascular Disease (CVD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Musculoskeletal Disorders
    • 5.6.1. Global Musculoskeletal Disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Stem Cell Therapy Market: Regional Estimates & Trend Analysis by Therapy Type, and Therapeutic Application

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. North America Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Switzerland
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Switzerland Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. South Korea Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Rest of World
    • 6.6.1. Rest of World Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2023
  • 7.4. Participant's Overview
    • 7.4.1. Bluebird Bio, Inc.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. NIPRO
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Orchard Therapeutics plc
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Pharmicell Co., Ltd.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. CorestemChemon Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. ANTEROGEN.CO.,LTD.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Holostem S.r.l.
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Vertex Pharmaceuticals, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Cleveland Cord Blood Center
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Gamida Cell Ltd.
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 4 Global stem cell therapy market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global stem cell therapy market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America stem cell therapy market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 8 North America stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 9 U.S. stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 10 U.S. stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 11 U.S. stem cell therapy market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Canada stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 13 Canada stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 14 Europe stem cell therapy market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 16 Europe stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 17 UK stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 18 UK stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 19 Germany stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 20 Germany stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 21 Switzerland stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 22 Switzerland stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 23 Asia Pacific stem cell therapy market, by country, 2018 - 2030 (USD Million)
  • Table 24 Asia Pacific stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 25 Asia Pacific stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 26 Japan stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 27 Japan stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 28 China stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 29 China stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 30 India stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 31 India stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 32 South Korea stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 33 South Korea stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 34 Rest of World stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 35 Rest of World stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 36 Participant's overview
  • Table 37 Financial performance
  • Table 38 Key companies undergoing expansions
  • Table 39 Key companies undergoing acquisitions
  • Table 40 Key companies undergoing collaborations
  • Table 41 Key companies launching new products
  • Table 42 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Stem cell therapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Stem cell therapy market driver analysis
  • Fig. 12 Stem cell therapy market restraint analysis
  • Fig. 13 Stem cell therapy market: Porter's analysis
  • Fig. 14 Stem cell therapy market: PESTEL analysis
  • Fig. 15 Stem cell therapy market: Therapy type outlook and key takeaways
  • Fig. 16 Stem cell therapy market: Therapy type market share analysis, 2023 - 2030
  • Fig. 17 Global stem cell therapy by allogeneic stem cell therapies market, 2018 - 2030 (USD Million)
  • Fig. 18 Global stem cell therapy by hematopoietic stem cell therapies market, 2018 - 2030 (USD Million)
  • Fig. 19 Global stem cell therapy by mesenchymal stem cell therapies market, 2018 - 2030 (USD Million)
  • Fig. 20 Global stem cell therapy by autologous stem cell therapies market, 2018 - 2030 (USD Million)
  • Fig. 21 Global stem cell therapy by BM, blood, & umbilical cord-derived stem cells market, 2018 - 2030 (USD Million)
  • Fig. 22 Global stem cell therapy by adipose derived cells market, 2018 - 2030 (USD Million)
  • Fig. 23 Global stem cell therapy by others market, 2018 - 2030 (USD Million)
  • Fig. 24 Stem cell therapy market: Therapeutical application outlook and key takeaways
  • Fig. 25 Stem cell therapy market: Therapeutical application market share analysis, 2023-2030
  • Fig. 26 Global stem cell therapy by oncology market, 2018 - 2030 (USD Million)
  • Fig. 27 Global stem cell therapy by cardiovascular disease (CVD) market, 2018 - 2030 (USD Million)
  • Fig. 28 Global stem cell therapy by musculoskeletal disorders market, 2018 - 2030 (USD Million)
  • Fig. 29 Global stem cell therapy by other market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 North America stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Canada stem cell therapy market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 UK stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Germany stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Switzerland stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Asia-Pacific stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Japan stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 China stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 India stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Rest of World stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Key company categorization
  • Fig. 45 Company market positioning
  • Fig. 46 Market participant categorization
  • Fig. 47 Strategy framework